00:48 , Oct 6, 2018 |  BioCentury  |  Finance

Seeking validation

The final stretch of the year offers clinical catalysts and early launch data that could validate investments in hot immuno-oncology targets and large untapped markets. Late-stage readouts from Vertex Pharmaceuticals Inc. in cystic fibrosis and...
03:04 , Jun 30, 2018 |  BioCentury  |  Finance

Eyes on launches

The annual summer slowdown isn’t restricted to just the stock market this year, as the clinical catalyst calendar also appears to be on holiday in 3Q18. Buysiders are therefore turning their attention to a spate...
00:43 , Jan 13, 2018 |  BioCentury  |  Finance

Choosy investors

  Despite losing steam in 4Q17, the broad-based recovery in biotech stocks last year has left investors generally comfortable with current valuations, and hence less optimistic that the sector indexes will outpace the broader market...
19:05 , Dec 8, 2017 |  BC Week In Review  |  Financial News

French Orphan play Advicenne raises EUR27M IPO

Advicenne S.A. (Euronext:ADVIC) lost €0.03 to €14 on its first day of trading Dec. 6 after it raised €27 million ($32.1 million) through the sale of 1.9 million shares at €14.03 in an IPO on...
00:41 , Dec 6, 2017 |  BC Extra  |  Financial News

French Orphan play Advicenne raises €27M IPO

Advicenne S.A. (Euronext:ADVIC) lost €0.03 to €14 on its first day of trading Wednesday after it raised €27 million ($32.1 million) through the sale of 1.9 million shares at €14.03 in an IPO on Euronext...
18:50 , Oct 27, 2017 |  BC Week In Review  |  Clinical News

Advicenne reports Phase III data for renal tubular acidosis candidate

In September, Advicenne Pharma S.A. (Nimes, France) reported data from a Phase III trial showing that among 30 evaluable patients with distal renal tubular acidosis, twice-daily oral ADV7103 was superior to standard of care (SOC)...
20:50 , Mar 23, 2017 |  BC Week In Review  |  Financial News

Advicenne completes venture financing

On March 20, pediatric renal and neurology company Advicenne Pharma S.A. (Nimes, France) raised €16 million ($17.2 million) in a financing round led by IDI SORIDEC Gestion, Cemag Invest and MI Care. Existing investors InnoBio...
07:00 , Oct 17, 2016 |  BC Week In Review  |  Clinical News

ADV6209 regulatory update

Primex submitted an MAA for ADV6209 under the EU’s decentralized procedure as moderate sedation prior to therapeutic or diagnostic procedures in children ages 6 months to 17 years. France is acting as the reference member...
07:00 , May 23, 2011 |  BC Week In Review  |  Financial News

Advicenne completes venture financing

Advicenne Pharma S.A. , Location undisclosed   Business: Renal, Neurology   Date completed: 5/13/11   Type: Venture financing   Raised: €5.1 million ($7.2 million)   Investors: iXO Private Equity; InnoBio Fund; private investors  ...